Estrogen/EGF receptor interactions in breast cancer: rationale for new therapeutic combination strategies
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference50 articles.
1. Epidermal growth factor receptor tyrosine kinase inhibitors in cancer therapy;Adjel;Drugs Future,2001
2. Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy;Archer;Br J Cancer,1995
3. Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site;Arteaga;J Biol Chem,1997
4. Expression of transforming growth factor-α and its messenger RNA in human breast cancer: its regulation by estrogen and its possible functional significance;Bates;Mol Endocrinol,1988
5. Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study;Bonneterre;J Clin Oncol,2000
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of tamoxifen treatment on the epidermal growth factor receptor expression in the mouse ovarian tissue;Uludağ Üniversitesi Veteriner Fakültesi Dergisi;2018-12-03
2. Exposure to EGF and 17β‑estradiol irreversibly affects the proliferation and transformation of MCF7 cells but is not sufficient to promote tumor growth in a xenograft mouse model upon withdrawal of exposure;International Journal of Molecular Medicine;2018-06-20
3. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival;Cellular Signalling;2017-04
4. Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells;Oncotarget;2016-11-08
5. Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors;Journal of Leukocyte Biology;2016-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3